Vanguard Personalized Indexing Management
MEDS

Vanguard Personalized Indexing Management’s DataMeds AI MEDS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-363
Closed -$7.26K – 2256
2025
Q4 		$7.26K Buy
+363
New +$10.6K ﹤0.01% 1971

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Personalized Indexing Management's MEDS Position: Q1 2026 in Review

Vanguard Personalized Indexing Management sold out of DataMeds AI (MEDS) in Q1 2026, closing a stake of 363 shares — an estimated $7.26K sold.

Vanguard Personalized Indexing Management first reported a position in MEDS in Q4 2025 and held it in 1 quarter. The position peaked at $7.26K in Q4 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

  • Vanguard Personalized Indexing Management reported no remaining DataMeds AI position as of Q1 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 363 DataMeds AI shares in Q1 2026, an estimated $7.26K.
  • Vanguard Personalized Indexing Management first reported a position in DataMeds AI in Q4 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's DataMeds AI position peaked at $7.26K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held DataMeds AI as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.